Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.
about
Novel roles for well-known players: from tobacco mosaic virus pests to enzymatically active assembliesSingle-dose monomeric HA subunit vaccine generates full protection from influenza challenge.Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivoAn induced hypersensitive-like response limits expression of foreign peptides via a recombinant TMV-based vector in a susceptible tobacco.Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens.Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivoPlant-Derived Chimeric Virus Particles for the Diagnosis of Primary Sjögren Syndrome.Plant-derived virus-like particles as vaccinesTransient expression systems for plant-derived biopharmaceuticals.Exploiting plant virus-derived components to achieve in planta expression and for templates for synthetic biology applications.Plant viral and bacteriophage delivery of nucleic acid therapeutics.Modified TMV Particles as Beneficial Scaffolds to Present Sensor Enzymes.A potential nanobiotechnology platform based on infectious bursal disease subviral particles.New viral vector for superproduction of epitopes of vaccine proteins in plants.Plant virus incorporated hydrogels as scaffolds for tissue engineering possess low immunogenicity in vivo.Complexes assembled from TMV-derived spherical particles and entire virions of heterogeneous nature.
P2860
Q26858808-8F3ECE5E-C8B8-4FD5-8FBE-F679B9888D6BQ30357409-659E1D72-EE01-44F5-8E2A-E15AD9D6FACCQ33517131-55A4D36D-1F82-40B7-A5DF-2C3332EC2484Q33760638-4A369F41-3DAE-4863-B9C1-C9EE83B3711DQ36186712-063324D3-6BCB-42E1-8AF2-58E712435FD1Q36267811-C069C99A-4E9C-4D87-999B-D9A5EC7C9A42Q36332891-2899D647-5A18-4804-BA3E-FD501C9A304DQ36888029-0A248A64-A78A-4CD5-87CF-7105BDBD6F66Q37776717-B525B62F-6011-4E70-ABA3-D3EFC8D06AB6Q38085709-17529117-7E0E-48B8-8C1B-F42350012E04Q39441748-7F3CD69B-9F6B-4F1E-AC25-373AB46E6509Q40997782-88915E7E-094C-42B2-98C4-E807B7EABB04Q41096939-21E8F289-C0D4-41A0-A191-F5CC47A9D3DCQ42003242-D62232C6-C5EF-415C-B00E-5487500614FAQ42218738-9567209E-F2DF-4100-B705-764DBB41CD1FQ42264389-C2CE9040-0FE0-4E7F-848A-836A5CEF9D81
P2860
Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.
@en
Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.
@nl
type
label
Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.
@en
Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.
@nl
prefLabel
Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.
@en
Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.
@nl
P2860
P356
P1476
Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.
@en
P2093
Alison A McCormick
Kenneth E Palmer
P2860
P356
10.1586/14760584.7.1.33
P577
2008-02-01T00:00:00Z